Phenomenon of tumor flare with talquetamab in a patient with extramedullary myeloma

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

Jedd D. Wolchok, Axel Hoos, Steven O’Day et al. · Clinical Cancer Research · 2009 · 3.2K citations

Medicine, Immunology, Oncology +17

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma

Ajai Chari, Monique C. Minnema, Jesús G. Berdeja et al. · New England Journal of Medicine · 2022 · 649 citations · Full text

Medicine, Immunology, Pharmacology +17

Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)

Asher Chanan‐Khan, Kena C. Miller, Kenichi Takeshita et al. · Blood · 2005 · 105 citations

Medicine, Oncology, Pharmacotherapy +12

Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia

Georg Aue, Ndegwa Njuguna, Xin Tian et al. · Haematologica · 2009 · 94 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma

Alexander M. Leipold, Rudolf A. Werner, Johannes Düll et al. · Leukemia · 2023 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17